Tabula Rasa HealthCare EBIT

Tabula Rasa HealthCare posts a EBIT of $-43M as of June 2023. That compares with $-58M in the prior-year period — up 25.8% year over year. That is below the Consumer Staples sector average of $24B. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Tabula Rasa HealthCare's EBIT was $-58M. The latest reading is $-43M — a 25.8% year-over-year increase (period ending June 2023). Use the history and growth charts on this page for a longer lookback.

For Consumer Staples stocks, a EBIT near $24B is typical. Tabula Rasa HealthCare's $-43M is lower that level. That is roughly 100.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of Tabula Rasa HealthCare's financial statement story. At $-43M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for TRHC's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $24B), and (3) consistency with growth and profitability. This page covers the first two; Tabula Rasa HealthCare's other metric pages and overview cover the third.